0
Article Tier 2 Detection Methods Human Health Effects Nanoplastics Policy & Risk Sign in to save

Communicating Confidence in the Reliability of Micro- and Nanoplastic Identification in Human Health Studies

Environment & Health 2026 2 citations

AI summary Read the abstract

This paper proposes a framework for improving confidence in how scientists identify and measure micro- and nanoplastics in human tissues and body fluids. The authors argue that studies need to use multiple complementary analysis methods and clearly report their limitations to produce reliable data. Better standardization in detection methods is critical for accurately assessing how much microplastic is actually inside people's bodies and what health risks it may pose.

Accurately quantifying and characterizing human internal exposure to micro- and nanoplastics are critical for assessing potential health risks. However, the detection of these particles in human tissues, fluids, cell systems, and relevant models remains a major analytical challenge. There is an urgent need for robust, selective, sensitive, and high-throughput methods capable of generating reliable quantitative data. Equally essential is the transparent reporting of methodological limitations and uncertainties, supported by rigorous data collection and standardized practices. These challenges are compounded by the ubiquity of plastic particles, and therefore the risk of sample contamination and their diverse properties (e.g., size, shape, composition), all adding to the complexity of identifying and quantifying them in biological matrices. To address these issues, we propose a framework that integrates orthogonal analytical techniques to enhance the data reliability. Commonly used analytical techniques for the analysis of micro- and nanoplastics are assigned a category based on their specificity when identifying plastic particles. The framework proposes minimum data requirements from orthogonal techniques for the identification of plastic particles at various confidence levels. Clear communication of analytical confidence is vital, and we present a structured approach to support this. We emphasize the importance of scientific integrity, rigorous study design, and transparent reporting in health research. Finally, we call for the universal adoption of harmonized confidence criteria for reporting the presence of plastics in humans, an essential step toward informed decision-making.

More Papers Like This

Article Tier 2

Communicating Confidence in the Reliability of Micro- and Nanoplastic Identification in Human Health Studies

AI summary Read the abstract

Researchers proposed a framework for assigning confidence levels to scientific measurements of micro- and nanoplastics in human tissues and fluids, using multiple complementary detection methods to improve reliability. Standardizing how scientists report these findings is critical, as inconsistent methods make it hard to assess the true health risks of plastic particles inside the human body.

Article Tier 2

Communicating confidence in the reliability of micro- and nanoplastic identification in human health studies

AI summary Read the abstract

Researchers propose a framework for improving the reliability of micro- and nanoplastic identification in human health studies by integrating multiple analytical techniques. The study emphasizes the need for transparent reporting of methodological limitations and introduces confidence levels for particle identification, addressing the major challenge of contamination risk and the diverse properties of plastic particles in biological samples.

Review Tier 2

Methods for identifying microplastics in human biofluids: scoping review

AI summary Read the abstract

Tiny plastic particles called microplastics are showing up in human body fluids, and scientists are still figuring out the best way to detect and measure them. This review looked at existing studies to compare the different testing methods researchers use, finding that there's currently no standard approach—which makes it hard to know exactly how much plastic is in our bodies or compare results across studies. This matters because before we can understand the health risks of microplastics, scientists need reliable, consistent ways to detect them in the first place.

Article Tier 2

Emerging Analytical Methodologies for Micro- and Nano-Plastics Detection in Human Samples: Analytical Challenges and Health Risk Perspectives

AI summary Read the abstract

Scientists have found tiny plastic particles (microplastics and even smaller nanoplastics) throughout human organs and body fluids, but this review of existing research shows we still lack reliable, standardized tools to accurately measure them—different labs get different results depending on how they prepare and test samples. While lab studies suggest very small plastic particles can cause cell stress and inflammation, there isn't yet solid evidence directly linking plastic exposure to specific diseases in people—so the biggest takeaway is that we urgently need better testing methods before we can truly understand the health risks these particles pose.

Review Tier 2

Methods for identifying microplastics in human biofluids: scoping review

AI summary Read the abstract

Scientists know tiny plastic particles called microplastics can end up in our blood, urine, and other body fluids, but this review reveals a big problem: researchers are using wildly different methods to detect and measure them, making it hard to compare results across studies or trust the numbers we're seeing. This matters because without consistent, reliable testing methods, we can't accurately answer basic questions like how much plastic is actually in our bodies or whether it's harming our health—so standardizing these techniques is a critical next step before we can draw firm conclusions.

Research digests by email

When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.

Email me about

Share this paper